Figure 2.
Schematic view of mutations in recurrently mutated signaling pathways in CTCLs. CTCL harbors recurrent mutations that are predicted to affect (A) T-cell activation/NF-κB signaling, (B) JAK/STAT signaling, (C) MAPK signaling, and (D) chromatin modifications. SNV, single nucleotide variation. Adapted from Park et al 2017. Used with permission from the American Society of Hematology.

Schematic view of mutations in recurrently mutated signaling pathways in CTCLs. CTCL harbors recurrent mutations that are predicted to affect (A) T-cell activation/NF-κB signaling, (B) JAK/STAT signaling, (C) MAPK signaling, and (D) chromatin modifications. SNV, single nucleotide variation. Adapted from Park et al 2017. Used with permission from the American Society of Hematology.

Close Modal

or Create an Account

Close Modal
Close Modal